Clinical trials
Phase 2 Multiple Myeloma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 5 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 10 |
| 2024 | 2 |
| 2025 | 10 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
| Unknown status | 13 |
| Completed | 9 |
| Active, not recruiting | 5 |
| Not yet recruiting | 5 |
| Withdrawn | 3 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 14 |
| Sun Yat-sen University | 3 |
| Celgene | 2 |
| Janssen Research & Development, LLC | 2 |
| Sanofi | 2 |
| The First Affiliated Hospital of Xiamen University | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| Xuzhou Medical University | 2 |
| Antengene Corporation | 1 |
| Chinese PLA General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 56 |
| Recurrence | 9 |
| Bites and Stings | 3 |
| Leukemia, Plasma Cell | 3 |
| Lymphoma | 2 |
| Neoplasm, Residual | 2 |
| Neoplasms | 2 |
| Neoplasms, Plasma Cell | 2 |
| Amyloidosis | 1 |
| Blood Protein Disorders | 1 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.